vs
Side-by-side financial comparison of InvenTrust Properties Corp. (IVT) and Phathom Pharmaceuticals, Inc. (PHAT). Click either name above to swap in a different company.
InvenTrust Properties Corp. is the larger business by last-quarter revenue ($77.4M vs $57.6M, roughly 1.3× Phathom Pharmaceuticals, Inc.). On growth, Phathom Pharmaceuticals, Inc. posted the faster year-over-year revenue change (94.1% vs 8.6%). InvenTrust Properties Corp. produced more free cash flow last quarter ($110.9M vs $-167.0M).
InvenTrust Properties Corp. is a real estate investment trust that invests in shopping malls. As of December 31, 2024, the company owned interests in 68 properties comprising 11.0 million square feet.
Phathom Pharmaceuticals is a clinical-stage biopharmaceutical firm focused on developing and commercializing innovative therapies for gastrointestinal diseases. Its lead product candidates address acid-related disorders, inflammatory bowel disease, and other GI conditions, serving patients mainly across North America and Europe.
IVT vs PHAT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $77.4M | $57.6M |
| Net Profit | $2.7M | — |
| Gross Margin | — | 86.7% |
| Operating Margin | -11.0% | — |
| Net Margin | 3.4% | — |
| Revenue YoY | 8.6% | 94.1% |
| Net Profit YoY | -72.8% | 71.6% |
| EPS (diluted) | $0.02 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $77.4M | $57.6M | ||
| Q3 25 | $74.5M | $49.5M | ||
| Q2 25 | $73.6M | $39.5M | ||
| Q1 25 | $73.8M | $28.5M | ||
| Q4 24 | $71.2M | $29.7M | ||
| Q3 24 | $68.5M | $16.4M | ||
| Q2 24 | $67.4M | $7.3M | ||
| Q1 24 | $66.8M | — |
| Q4 25 | $2.7M | — | ||
| Q3 25 | $6.0M | $-30.0M | ||
| Q2 25 | $95.9M | $-75.8M | ||
| Q1 25 | $6.8M | $-94.3M | ||
| Q4 24 | $9.8M | — | ||
| Q3 24 | $-539.0K | $-85.6M | ||
| Q2 24 | $1.5M | $-91.4M | ||
| Q1 24 | $2.9M | — |
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 87.5% | ||
| Q2 25 | — | 87.2% | ||
| Q1 25 | — | 86.9% | ||
| Q4 24 | — | 87.1% | ||
| Q3 24 | — | 85.6% | ||
| Q2 24 | — | 81.2% | ||
| Q1 24 | — | — |
| Q4 25 | -11.0% | — | ||
| Q3 25 | -9.8% | -30.8% | ||
| Q2 25 | — | -151.7% | ||
| Q1 25 | -10.5% | -276.5% | ||
| Q4 24 | -3.6% | — | ||
| Q3 24 | -18.7% | -433.0% | ||
| Q2 24 | -13.6% | -1055.4% | ||
| Q1 24 | -13.1% | — |
| Q4 25 | 3.4% | — | ||
| Q3 25 | 8.1% | -60.5% | ||
| Q2 25 | 130.4% | -191.9% | ||
| Q1 25 | 9.2% | -330.7% | ||
| Q4 24 | 13.8% | — | ||
| Q3 24 | -0.8% | -523.3% | ||
| Q2 24 | 2.2% | -1248.6% | ||
| Q1 24 | 4.3% | — |
| Q4 25 | $0.02 | — | ||
| Q3 25 | $0.08 | $-0.41 | ||
| Q2 25 | $1.23 | $-1.05 | ||
| Q1 25 | $0.09 | $-1.31 | ||
| Q4 24 | $0.14 | — | ||
| Q3 24 | $-0.01 | $-1.32 | ||
| Q2 24 | $0.02 | $-1.56 | ||
| Q1 24 | $0.04 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $130.0M |
| Total DebtLower is stronger | $825.9M | $209.1M |
| Stockholders' EquityBook value | $1.8B | $-438.2M |
| Total Assets | $2.8B | $259.1M |
| Debt / EquityLower = less leverage | 0.46× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $130.0M | ||
| Q3 25 | — | $135.2M | ||
| Q2 25 | — | $149.6M | ||
| Q1 25 | — | $212.3M | ||
| Q4 24 | — | $297.3M | ||
| Q3 24 | — | $334.7M | ||
| Q2 24 | — | $276.2M | ||
| Q1 24 | — | — |
| Q4 25 | $825.9M | $209.1M | ||
| Q3 25 | $764.6M | $207.1M | ||
| Q2 25 | $746.3M | $205.1M | ||
| Q1 25 | $740.7M | $203.2M | ||
| Q4 24 | $740.4M | $201.4M | ||
| Q3 24 | $740.1M | $175.7M | ||
| Q2 24 | $812.2M | $174.4M | ||
| Q1 24 | $827.5M | — |
| Q4 25 | $1.8B | $-438.2M | ||
| Q3 25 | $1.8B | $-422.5M | ||
| Q2 25 | $1.8B | $-405.8M | ||
| Q1 25 | $1.7B | $-338.4M | ||
| Q4 24 | $1.8B | $-253.6M | ||
| Q3 24 | $1.8B | $-187.1M | ||
| Q2 24 | $1.5B | $-233.8M | ||
| Q1 24 | $1.5B | — |
| Q4 25 | $2.8B | $259.1M | ||
| Q3 25 | $2.7B | $240.3M | ||
| Q2 25 | $2.7B | $250.2M | ||
| Q1 25 | $2.6B | $294.2M | ||
| Q4 24 | $2.6B | $378.3M | ||
| Q3 24 | $2.6B | $387.0M | ||
| Q2 24 | $2.5B | $319.4M | ||
| Q1 24 | $2.5B | — |
| Q4 25 | 0.46× | — | ||
| Q3 25 | 0.42× | — | ||
| Q2 25 | 0.41× | — | ||
| Q1 25 | 0.42× | — | ||
| Q4 24 | 0.42× | — | ||
| Q3 24 | 0.42× | — | ||
| Q2 24 | 0.53× | — | ||
| Q1 24 | 0.53× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $155.4M | $-166.8M |
| Free Cash FlowOCF − Capex | $110.9M | $-167.0M |
| FCF MarginFCF / Revenue | 143.3% | -290.0% |
| Capex IntensityCapex / Revenue | 57.5% | 0.4% |
| Cash ConversionOCF / Net Profit | 58.41× | — |
| TTM Free Cash FlowTrailing 4 quarters | $193.1M | $-328.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $155.4M | $-166.8M | ||
| Q3 25 | $43.8M | $-14.1M | ||
| Q2 25 | $48.7M | $-62.7M | ||
| Q1 25 | $20.2M | $-84.9M | ||
| Q4 24 | $136.9M | $-266.8M | ||
| Q3 24 | $38.4M | $-63.6M | ||
| Q2 24 | $46.7M | $-70.7M | ||
| Q1 24 | $14.8M | — |
| Q4 25 | $110.9M | $-167.0M | ||
| Q3 25 | $31.4M | $-14.1M | ||
| Q2 25 | $38.0M | $-62.8M | ||
| Q1 25 | $12.8M | $-84.9M | ||
| Q4 24 | $100.8M | $-266.9M | ||
| Q3 24 | $29.3M | $-63.6M | ||
| Q2 24 | $37.2M | $-70.8M | ||
| Q1 24 | $7.7M | — |
| Q4 25 | 143.3% | -290.0% | ||
| Q3 25 | 42.2% | -28.6% | ||
| Q2 25 | 51.6% | -159.0% | ||
| Q1 25 | 17.4% | -297.9% | ||
| Q4 24 | 141.5% | -899.8% | ||
| Q3 24 | 42.8% | -389.0% | ||
| Q2 24 | 55.2% | -966.2% | ||
| Q1 24 | 11.5% | — |
| Q4 25 | 57.5% | 0.4% | ||
| Q3 25 | 16.7% | 0.1% | ||
| Q2 25 | 14.6% | 0.2% | ||
| Q1 25 | 10.0% | 0.1% | ||
| Q4 24 | 50.7% | 0.5% | ||
| Q3 24 | 13.3% | 0.3% | ||
| Q2 24 | 14.0% | 0.6% | ||
| Q1 24 | 10.6% | — |
| Q4 25 | 58.41× | — | ||
| Q3 25 | 7.27× | — | ||
| Q2 25 | 0.51× | — | ||
| Q1 25 | 2.97× | — | ||
| Q4 24 | 13.97× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 31.15× | — | ||
| Q1 24 | 5.10× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
